Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 18/20 | 1.00 |
| ▸ | HSP90AB1 | P08238 | 18/20 | 1.00 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13627475 | 0.82 | HSP90AA1 (0.70) | HSP90AA1HSP90AB1DRD2 | |
| SCHEMBL21067316 | 0.76 | HSP90AA1 (1.00) | HSP90AA1HSP90AB1 | |
| SCHEMBL15225022 | 0.68 | HSP90AA1 (0.52) | HSP90AA1HSP90AB1DRD2 | |
| SCHEMBL13627483 | 0.68 | HSP90AA1 (0.53) | HSP90AA1HSP90AB1ALDH1A1 | |
| SCHEMBL20831462 | 0.67 | TRPC5 (0.77) | HSP90AA1HSP90AB1ALDH1A1 | |
| SCHEMBL13627519 | 0.67 | HSP90AA1 (0.51) | HSP90AA1HSP90AB1ALDH1A1 | |
| SCHEMBL22516947 | 0.67 | DRD2 (0.56) | HSP90AA1HSP90AB1DRD2ALDH1A1 | |
| SCHEMBL13627494 | 0.67 | HSP90AA1 (0.50) | HSP90AA1HSP90AB1ALDH1A1 | |
| SCHEMBL13627487 | 0.66 | HSP90AA1 (0.49) | HSP90AA1HSP90AB1ALDH1A1 | |
| SCHEMBL13627503 | 0.66 | HSP90AA1 (0.52) | HSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |